http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-100382795-C
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f16a6d8b1582fd7a69644084ed7aa3c9 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-164 |
| filingDate | 2004-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2008-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0acb059516b99d804f1ba96dfec6d40e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6187e6deb5cfebfe95985de14e3d9642 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15721e593fd0855f35fe56fbf03fe4fb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4762b71be50473e7b1f2090f0f465be7 |
| publicationDate | 2008-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-100382795-C |
| titleOfInvention | Glycinamide derivative for inhibiting HIV replication |
| abstract | The present invention relates to the discovery of a novel class of compounds that inhibit the replication of human immunodeficiency virus (HIV) and approaches to identify these compounds. More specifically, it has been found that enzymatically prepared alpha-hydroxyglycinamide and synthetically prepared alpha-hydroxyglycinamide inhibit the replication of HIV in human serum. Embodiments include methods to identify modified glycinamide compounds that inhibit HIV, methods to isolate and synthesize modified glycinamide compounds, and therapeutic compositions comprising these compounds. |
| priorityDate | 2003-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 300.